Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Jaromir Zatloukal (Olomouc, Czech Republic), Jaromir Zatloukal, Vladimir Koblizek, Marek Plutinsky, Patrice Popelkova, Tomas Dvorak, Petr Safranek, Ondrej Sobotik, Alena Vlachova, Petr Vanik, Zuzana Liptakova, Lucie Heribanova, Blanka Snelerova, Pavlina Musilova, Maria Majerciakova, Tomas Vencalek, Eva Kocova, Barbora Novotna, Michal Kopecky, Ondrej Kudela, Katerina Neumannova, Kristian Brat, Eva Volakova, Karel Hejduk, Jan Svancara, Jiri Jarkovsky, Michal Svoboda, Zuzana Zbozinkova. COPD therapy based on clinical phenotypes: Baseline data from the Czech multicentre research database of COPD. Eur Respir J 2015; 46: Suppl. 59, 1058

Member's Comments

No comment yet.

Related content which might interest you: Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Respiratory parameters predict mortality in COPD patients - data from the Czech multicentre research database of severe COPD. Source: International Congress 2017 – Markers of COPD progression Year: 2017 Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS) Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016 Evolution of COPD phenotypes in time - Czech multicentre research database of severe COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Effect of COPD medications on exacerbation rates in a real-life COPD patient cohort - data from the Czech Multicenter Research Database of COPD. Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Patients’ adherence to chronic treatment in lung diseases: Preliminary data from a randomized controlled trial Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Clinical, functional and laboratory assessment of treatment efficacy in COPD patients Source: International Congress 2014 – Predictors Year: 2014 Efficacy and safety of erdosteine in COPD: Results of a 12-month prospective, multinational study Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 A non-interventional observational trial to study the COPD treatment choices in routine clinical practice in Bulgaria Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013 COPD severity analysis according to current evaluation criteria – National survey Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Long-term survivalaccording to Czech clinical phenotypes of COPD- Czech multicentre research database of severe COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Roflumilast for stable COPD: Meta-analysis of randomized controlled trials Source: International Congress 2014 – Clinical presentations Year: 2014 Comprehensive care programme for patients with chronic obstructive pulmonary disease (COPD) --- A randomized controlled trial (RCT) Source: International Congress 2015 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2015 An Italian, observational, multicentre trial to describe treatment management in COPD patients: Preliminary results of the MISTRAL study Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Top-10 comorbidities of symptomatic patients with moderate COPD in the clinical setting of the CRYSTAL study Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Costs and effects of structured COPD care – An observational, matched-cohort study Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care Year: 2013 COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study Source: International Congress 2014 – Markers Year: 2014 Validation of the recording of acute exacerbations of COPD in the clinical practice research datalink: Phase 1 results Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Agreement between patient-reported and chart documented outcomes: Case study in COPD Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013